Injectable drug shortages may ease with rising interest, WSJ reports

theflyonthewall.com

The shortage of injectable drugs used by hospitals could ease as more healthcare companies look to become new manufacturers, Wall Street Journal reports. Becton Dickinson (BDX) became the latest player in the $7B market with yesterday's approval for an antihistamine, the paper adds.

View Comments